502132-86-7 Usage
Uses
Used in Pharmaceutical Research and Drug Design:
3-Amino-5-(2-fluorophenyl)-1H-pyrazole is used as a building block for the synthesis of new drugs and bioactive molecules, owing to its unique chemical structure and reactivity. Its presence in the development of pharmaceutical compounds can contribute to the discovery of novel therapeutic agents with improved efficacy and selectivity.
Used in Medicinal Chemistry:
3-Amino-5-(2-fluorophenyl)-1H-pyrazole is utilized as a key component in the design and synthesis of pharmaceutical compounds, allowing researchers to explore its potential in treating various diseases and conditions. Its incorporation into drug candidates can lead to the development of innovative treatments with enhanced pharmacological properties.
Used in Organic Synthesis:
3-Amino-5-(2-fluorophenyl)-1H-pyrazole serves as a versatile intermediate in organic synthesis, enabling the creation of a wide range of organic compounds with diverse applications. Its unique structure and reactivity make it an attractive candidate for the synthesis of complex organic molecules, including those with potential applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 502132-86-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,2,1,3 and 2 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 502132-86:
(8*5)+(7*0)+(6*2)+(5*1)+(4*3)+(3*2)+(2*8)+(1*6)=97
97 % 10 = 7
So 502132-86-7 is a valid CAS Registry Number.
InChI:InChI=1/C9H8FN3/c10-7-4-2-1-3-6(7)8-5-9(11)13-12-8/h1-5H,(H3,11,12,13)
502132-86-7Relevant articles and documents
ANTAGONISTS OF THE ADENOSINE A2A RECEPTOR
-
Paragraph 001105-001107, (2021/11/13)
The present invention relates to compounds of formula I shown below: wherein R0, R1, R2, R3 and A are each as defined in the application. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of diseases or conditions in which adenosine A2a receptor activity is implicated, such as, for example, cancer.
ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR INHIBITORS
-
Page/Page column 94, (2010/04/03)
The present invention provides compounds and compositions, methods of making them, and methods of using them to modulate α7 nicotinic acetylcholine receptors and/or to treat any of a variety of disorders, diseases, and conditions. Provided compounds can a
NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS
-
Page/Page column 62, (2008/12/07)
The present invention provides compounds of formula (I) and compositions thereof, methods of making them, and methods of using them to modulate alpha7 nicotinic acetylcholine receptors and/or to treat any of a variety of disorders, diseases, and conditions. Provided compounds can affect, among other things, neurological, psychiatric and/or inflammatory system.